Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1971 Dec;68(12):3136–3139. doi: 10.1073/pnas.68.12.3136

Reaction of Anti-idiotypic Antibody with the Hapten-Binding Site of a Myeloma Protein

Bruce W Brient *, Joseph Haimovich †,, Alfred Nisonoff §
PMCID: PMC389607  PMID: 4108873

Abstract

Rabbit antiserum was prepared against mouse myeloma Protein-315, an IgA protein with specificiy toward the 2,4-dinitrophenyl group. After absorption of the antiserum with another IgA myeloma protein and with affinity-labeled Protein-315, the antiserum was specific for idiotypic determinants on Protein-315. Monovalent ligands that bind to Protein-315 with high affinity strongly inhibited the reaction of the protein with its anti-idiotypic antiserum. This indicated that the region of the hapten-binding site is a major idiotypic determinant. The myeloma protein is thus similar to rabbit antibenzoate antibody in this respect. These results, considered in conjunction with other data in the literature, indicate that an anti-idiotypic antiserum prepared in an isologous or heterologous species can recognize the same determinant, in this case the region comprising the ligand-binding site. Quantitative aspects of the data indicate that there is competition between the hapten and antiidiotypic antibodies for the site.

Keywords: mice, plasma cell tumor, antigenic determinant, rabbit, Fab

Full text

PDF
3136

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brient B. W., Nisonoff A. Quantitative investigations of idiotypic antibodies. IV. Inhibition by specific haptens of the reaction of anti-hapten antibody with its anti-idiotypic antibody. J Exp Med. 1970 Nov;132(5):951–962. doi: 10.1084/jem.132.5.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Eisen H. N., Michaelides M. C., Underdown B. J., Schulenburg E. P., Simms E. S. Experimental approaches to homogenous antibody populations. Myeloma proteins with antihapten antibody activity. Fed Proc. 1970 Jan-Feb;29(1):78–84. [PubMed] [Google Scholar]
  3. Eisen H. N., Simms E. S., Potter M. Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315. Biochemistry. 1968 Nov;7(11):4126–4134. doi: 10.1021/bi00851a048. [DOI] [PubMed] [Google Scholar]
  4. GREY H. M., MANNIK M., KUNKEL H. G. INDIVIDUAL ANTIGENIC SPECIFICITY OF MYELOMA PROTEINS. CHARACTERISTICS AND LOCALIZATION TO SUBUNITS. J Exp Med. 1965 Apr 1;121:561–575. doi: 10.1084/jem.121.4.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Haimovich J., Givol D., Eisen H. N. Affinity labeling of the heavy and light chains of a myeloma protein with anti-2,4-dinitrophenyl activity. Proc Natl Acad Sci U S A. 1970 Dec;67(4):1656–1661. doi: 10.1073/pnas.67.4.1656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hopper J. E., MacDonald A. B., Nisonoff A. Quantitative investigations of idiotypic antibodies. II. Nonprecipitating antibodies. J Exp Med. 1970 Jan 1;131(1):41–56. doi: 10.1084/jem.131.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kunkel H. G., Mannik M., Williams R. C. Individual Antigenic Specificity of Isolated Antibodies. Science. 1963 Jun 14;140(3572):1218–1219. doi: 10.1126/science.140.3572.1218. [DOI] [PubMed] [Google Scholar]
  8. McConahey P. J., Dixon F. J. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966;29(2):185–189. doi: 10.1159/000229699. [DOI] [PubMed] [Google Scholar]
  9. OUDIN J., MICHEL M. [A new allotype form of rabbit serum gamma-globulins, apparently associated with antibody function and specificity]. C R Hebd Seances Acad Sci. 1963 Jul 17;257:805–808. [PubMed] [Google Scholar]
  10. Oudin J. The genetic control of immunoglobulin synthesis. Proc R Soc Lond B Biol Sci. 1966 Nov 22;166(1003):207–221. doi: 10.1098/rspb.1966.0094. [DOI] [PubMed] [Google Scholar]
  11. Parker C. W., Osterland C. K. Hydrophobic binding sites on immunoglobulins. Biochemistry. 1970 Mar 3;9(5):1074–1082. doi: 10.1021/bi00807a004. [DOI] [PubMed] [Google Scholar]
  12. Potter M., Lieberman R. Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline. J Exp Med. 1970 Oct 1;132(4):737–751. doi: 10.1084/jem.132.4.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SLATER R. J., WARD S. M., KUNKEL H. G. Immunological relationships among the myeloma proteins. J Exp Med. 1955 Jan 1;101(1):85–108. doi: 10.1084/jem.101.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schulenburg E. P., Simms E. S., Lynch R. G., Bradshaw R. A., Eisen H. N. Amino acid sequence of the light chain from a mouse myeloma protein with anti-hapten activity: evidence for a third type of light chain. Proc Natl Acad Sci U S A. 1971 Nov;68(11):2623–2626. doi: 10.1073/pnas.68.11.2623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sirisinha S., Eisen H. N. Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins. Proc Natl Acad Sci U S A. 1971 Dec;68(12):3130–3135. doi: 10.1073/pnas.68.12.3130. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES